≡

Recombinant Plexin B1 (PLXNB1)

PLXN5; SEP; Semaphorin receptor SEP

  • Product No.RPH358Hu04
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationMembrane, Secreted
  • Predicted Molecular Mass45.0kDa
  • Accurate Molecular Mass42kDa(Analysis of differences refer to the manual)
  • Residues & TagsLeu581~Gly727 with N-terminal His and GST Tag
  • Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 90%
  • Isoelectric Point5.5
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 172  US$ 430  US$ 860  US$ 2580  US$ 6450 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Expert Opin Ther Targets. Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment Pubmed:25395071
Clinical Lymphoma, Myeloma & Leukemia A Revised Staging System for Waldenström's Macroglobulinemia 10.1016/j.clml.2017.07.146
Clinical Lymphoma, Myeloma & Leukemia Extramedullary Multiple Myeloma: Clinical Features and Prognosis in Argentina 10.1016/j.clml.2017.07.144
Blood Cancer Journal Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma Pubmed:29748532
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPH358Hu04 Recombinant Plexin B1 (PLXNB1) Positive Control; Immunogen; SDS-PAGE; WB.
RPH358Hu03 Recombinant Plexin B1 (PLXNB1) Positive Control; Immunogen; SDS-PAGE; WB.
RPH358Hu02 Recombinant Plexin B1 (PLXNB1) Positive Control; Immunogen; SDS-PAGE; WB.
RPH358Hu01 Recombinant Plexin B1 (PLXNB1) Positive Control; Immunogen; SDS-PAGE; WB.
PAH358Hu01 Polyclonal Antibody to Plexin B1 (PLXNB1) WB
PAH358Hu03 Polyclonal Antibody to Plexin B1 (PLXNB1) WB; IHC; ICC; IP.
PAH358Hu02 Polyclonal Antibody to Plexin B1 (PLXNB1) WB; IHC; ICC; IP.
SEH358Hu ELISA Kit for Plexin B1 (PLXNB1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMH358Hu Multiplex Assay Kit for Plexin B1 (PLXNB1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.